Cargando…

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults

BACKGROUND: Adults with certain comorbid conditions have a higher risk of pneumonia than the overall population. If treatment of pneumonia is more costly in certain predictable situations, this would affect the value proposition of populations for pneumonia prevention. We estimate the economic impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polsky, Daniel, Bonafede, Machaon, Suaya, Jose A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585380/ https://www.ncbi.nlm.nih.gov/pubmed/23113880 http://dx.doi.org/10.1186/1472-6963-12-379

Ejemplares similares

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Care Among Migraine Patients in a Commercially Insured Population
por: Bonafede, Machaon, et al.
Publicado: (2020)

Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
por: Sato, Reiko, et al.
Publicado: (2013)

Skin and Soft Tissue Infections and Associated Complications among Commercially Insured Patients Aged 0–64 Years with and without Diabetes in the U.S.
por: Suaya, Jose A., et al.
Publicado: (2013)

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data
por: Gharaibeh, Mahdi, et al.
Publicado: (2020)

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives
por: Miller, Jeffrey D., et al.
Publicado: (2015)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives
por: Miller, Jeffrey D, et al.
Publicado: (2015)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
por: Bonafede, Machaon, et al.
Publicado: (2021)

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
por: Bonafede, Machaon M, et al.
Publicado: (2013)

Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
por: Johnson, Barbara H., et al.
Publicado: (2015)

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
por: Johnson, Barbara H, et al.
Publicado: (2016)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs
por: Bonafede, Machaon M, et al.
Publicado: (2014)

Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera
por: Parasuraman, Shreekant V., et al.
Publicado: (2018)

Correction: Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
por: Howe, Sarah J., et al.
Publicado: (2022)

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Work, sleep, and cholesterol levels of U.S. long-haul truck drivers
por: LEMKE, Michael K., et al.
Publicado: (2016)

Drivers and sequelae of burnout in U.S. dermatology trainees
por: Marchalik, Rachel, et al.
Publicado: (2021)

Changing patterns of use of implantable cardiac monitors from 2011 to 2018 for a large commercially-insured U.S. population
por: Ellenbogen, Michael I., et al.
Publicado: (2021)

Commercial Driver Medical Examinations: Prevalence of Obesity, Comorbidities, and Certification Outcomes
por: Thiese, Matthew S., et al.
Publicado: (2015)

Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data
por: Beyrer, Julie, et al.
Publicado: (2021)

Association Between Length of Residence in the U.S. and Insurance Coverage Within U.S. Chinese Older Adults
por: Tuseth, Natalie, et al.
Publicado: (2021)

Association Between Length of Residence in the U.S. and Insurance Coverage Within U.S. Chinese Older Adults
por: Tuseth, Natalie, et al.
Publicado: (2021)

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
por: Kern, David M, et al.
Publicado: (2015)

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2016)

Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
por: Mannie, Cristina, et al.
Publicado: (2020)

Availability of Insurance Linkage Programs in U.S. Emergency Departments
por: Kanak, Mia, et al.
Publicado: (2014)

Variability of assister availability in health insurance marketplace in the U.S.
por: Han, Jayoung, et al.
Publicado: (2018)

U.S. Unemployment insurance through the Covid-19 crisis
por: Spadafora, Francesco
Publicado: (2023)

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
por: Bonafede, Machaon, et al.
Publicado: (2014)

Ambulatory Health Care Service Use and Costs Among Commercially Insured US Adults With Congenital Heart Disease
por: Agarwal, Anushree, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mivepf91p5j2250f12pdufq11